Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark J. Sarno
NADiA ProsVue Prostate-Specific Antigen Slope Is an Independent Prognostic Marker for Identifying Men at Reduced Risk of Clinical Recurrence of Prostate Cancer After Radical Prostatectomy
Urology
Urology
Related publications
Maximum Tumor Diameter Is an Independent Predictor of Prostate-Specific Antigen Recurrence in Prostate Cancer
Modern Pathology
Forensic Medicine
Pathology
Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Framework to Evaluate the Cost-Effectiveness of the NADiA ProsVue Slope to Guide Adjuvant Radiotherapy Among Men With High-Risk Characteristics Following Prostatectomy for Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Over-Expression of Extracellular Matrix Metalloproteinase Inducer in Prostate Cancer Is Associated With High Risk of Prostate-Specific Antigen Relapse After Radical Prostatectomy
Clinical and Investigative Medicine
Medicine
Prostate-Specific Antigen Is a Predictor of the Efficacy of Salvage Radiation Therapy in Patients With Recurrent Prostate Cancer After Radical Prostatectomy
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Prostate Cancer Biochemical Recurrence Rates After Robotic-Assisted Laparoscopic Radical Prostatectomy
Journal of the Society of Laparoendoscopic Surgeons
Surgery
Usefulness of Ultra‑sensitive Prostate‑specific Antigen Following Radical Prostatectomy
Molecular and Clinical Oncology
Cancer Research
Oncology
ERG Immunohistochemistry Is Not Predictive for PSA Recurrence, Local Recurrence or Overall Survival After Radical Prostatectomy for Prostate Cancer
Modern Pathology
Forensic Medicine
Pathology
Prostate-Specific Antigen (PSA) Assay for Early Detection of Prostate Cancer Recurrence
Science-Business eXchange
